- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 307/64 - Atomes de soufre
Détention brevets de la classe C07D 307/64
Brevets de cette classe: 168
Historique des publications depuis 10 ans
|
9
|
12
|
13
|
17
|
13
|
16
|
12
|
4
|
6
|
5
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Cardioxyl Pharmaceuticals, Inc. | 38 |
16 |
| Novartis AG | 10169 |
13 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 177 |
8 |
| The University of Queensland | 651 |
8 |
| Allergan, Inc. | 2148 |
7 |
| Sironix Renewables, Inc. | 17 |
5 |
| JSR Corporation | 2553 |
4 |
| Canopy Growth Corporation | 211 |
4 |
| Regents of the University of Minnesota | 2809 |
4 |
| Novartis Inflammasome Research, Inc. | 10 |
4 |
| Imperial College Innovations Limited | 695 |
3 |
| Oxford Drug Design Limited | 11 |
3 |
| IFM Tre, Inc. | 5 |
3 |
| BASF SE | 21320 |
2 |
| Askat Inc. | 49 |
2 |
| Astellas Institute for Regenerative Medicine | 122 |
2 |
| Cadila Healthcare Limited | 290 |
2 |
| Chengdu Baiyu Pharmaceutical Co., Ltd. | 68 |
2 |
| Elara Pharmaceuticals GmbH | 9 |
2 |
| European Molecular Biology Laboratory (embl) | 22 |
2 |
| Autres propriétaires | 72 |